Drug testing with angiogenesis models

ISSN： 1746-0441

Source： Expert Opinion on Drug Discovery, Vol.3, Iss.5, 2008-05, pp. : 533-549

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

In Vivo Models of Childhood Leukemia for Preclinical Drug Testing

Current Drug Targets, Vol. 8, Iss. 6, 2007-06 ,pp. : 773-783

Bentham Science Publishers

Access to resources Recommend Favorite

Toxicogenetics: population-based testing of drug and chemical safety in mouse models

By Rusyn Ivan Gatti Daniel M Wilshire Timothy Kleeberger Steven R Threadgill David W

Pharmacogenomics, Vol. 11, Iss. 8, 2010-08 ,pp. : 1127-1136

Future Medicine

Access to resources Recommend Favorite

Models for the Study of Angiogenesis

Current Pharmaceutical Design, Vol. 14, Iss. 4, 2008-02 ,pp. : 371-377

Bentham Science Publishers

Access to resources Recommend Favorite

Human Embryonic and Induced Pluripotent Stem Cell Based Toxicity Testing Models: Future Applications in New Drug Discovery

Current Medicinal Chemistry, Vol. 23, Iss. 30, 2016-10 ,pp. : 3495-3509

Bentham Science Publishers

Access to resources Recommend Favorite

Discovery and validation of drug targets for tumour angiogenesis

By Kremmidiotis Gabriel Lavranos Tina C

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 2, 2005-04 ,pp. : 211-215

Informa Healthcare

Access to resources Recommend Favorite